EMCDDA Home
  • EN
Search

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2011 or most recent year available

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drugAmphetaminesMDMA and other derivatives
Opioids3706
Cocaine11914
Stimulants (other than cocaine)15216
Hypnotics and sedatives3254
Hallucinogens607
Volatile250
Cannabis 143329
Alcohol50712
Other substances 562
Total number of citations304790
 

Notes

Clients may report one primary drug, but more than one secondary drug

For information relative to the countries included please see Table TDI-7

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI by centre type.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013